维普中文期刊产品整合服务
18篇 您的检索式:作者名="CortesJ"
    题名 作者 年代 出处 被引量
1Front?line paclitaxel/' cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer显示文摘CORTESJ RODRIGUEZJ ARAMENDIAJ M 2003Oncology2003,64,:1
2Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation显示文摘CortesJ LiptonJH ReaD 2012Blood2012,120,13:1
3Imatinibmesylatetherapy in newly diagnosed patients with Philadelphia chromosome - positive chronic myelogenous leukemia: high incidence of early complete and major cytogenetic responses显示文摘KantarjianHM CortesJE O'BrienS 2003Blood2003,101,1:1
4AP24534, a pan-BCR?ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance显示文摘CortesJ Talpaz M Deininger M 2009Blood2009,114,:1
5Chronic myelogenous leukemia显示文摘Druker BJ O'Brien SG CortesJ 2002Hematol (Am Soc Hematol Educ Program)2002,111,:1
6Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome:predictive prognostic models for outcome显示文摘KantarjianH O' brienS CortesJ 2006Cancer2006,106,5:1
7Biology of platelet?derived growth factor and its involvement in disease 显示文摘Alvarez R H Kantarjian H M CortesJ E 2006Mayo Clin Proc2006,81,9:1
8Evolution of players' misperceptions in hypergames under perfect observations显示文摘Gharesifard B CortesJ 2012IEEE Transactions on Automatic Control2012,57,7:1
9Persistence of peripheral blood and bone marrow blasts during remission induction in adult acute lymphoblastic leukemia confers a poor prognosis depending on treatment intensity 显示文摘CortesJ FayadL O'BrienS 1999Clin Cancer Res1999,5,24:1
10Treatment of Philadelphia chromosome- positive acute lymphocytic leukemia with hyper?CVAD and imatinib mesylate显示文摘Thomas DA Fader! S CortesJ et a1 2004Blood2004,103,12:1
11Which type of tourism matters for the regional economic growth? The case of Spain and Italy显示文摘CortesJ I 2008Interna?tional o[Journal of Tourism Research2008,10,2:1
12Dasatinib or imatinib in newly diagnosed chronic- phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)显示文摘Kantarjian HM Shah NP CortesJE 2012Blood2012,119,5:1
13How I treat newly diagnosed chronic phase CML显示文摘CortesJ Kantarjian H 2012Blood2012,120,7:1
14Bosutinib versus imatinib in newly diagnosed chronic- phase chronic myeloid leukemia: results from the BELA trial显示文摘CortesJE Kim DW Kantarjian HM 2012J Clin Oncol2012,30,28:1
15Ponatinib in refractory Philadelphia chromosome-positive leukemias显示文摘CortesJE Kantarjian H Shah NP 2012N EnglJ Med2012,367,22:1
16Phase II study of low dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate 显示文摘IssaJP Gharibyan V CortesJ 2005J Clin Oncol2005,23,17:1
17Treatment of Philadelphia chromosome- positive acute lymphocytic leukemia with hyper?CVAD and imatinib mesylate显示文摘Thomas DA Fader! S CortesJ 2004Blood2004,103,12:1
18Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure显示文摘JabbourE CortesJ KantarjianHM 2006Blood2006,108,4:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费